B-TEMIA Announces a Medical Breakthrough for Individuals With Limited Walking Endurance

Keeogo™ unveiled at the Canadian Seating Mobility & More Conference in Toronto.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Quebec, May 13, 2014 (PRWEB) May 13, 2014

B-TEMIA Inc. announces today the first public unveiling of Keeogo™ (http://www.keeogo.com) at the Canadian Seating Mobility & More Conference in Toronto.

Keeogo™ is a motorized walking assistive device worn on the lower body that provides individuals with the leg power they need to walk more, better and keep on going throughout their day. Keeogo™ is designed for individuals who have limited walking endurance or mobility issues resulting of muscle weakness, aging in general or due to a number of medical conditions including Multiple Sclerosis, Parkinson’s disease or a cardiovascular condition such as peripheral artery diseases.

“Regaining autonomy in mobility is so critical to an individual’s health and well being. We are excited to unveil Keeogo™ and look forward to helping many Canadians,” comments Mr. Stéphane Bédard, President and CEO of B-TEMIA.

Keeogo™ is being demonstrated this week at booth 103 at the Canadian Seating Mobility & More Conference in Toronto.

B-TEMIA Inc. is a private medical device company that develops and markets products in the growing market of mobility assistive devices. Based in Quebec City (Canada), B-TEMIA operates through two wholly-owned subsidiaries, B-TEMIA Health Inc. and B-TEMIA Military Inc. B-TEMIA owns a patent-pending wearable dermoskeleton technology that restores, maintains or enhances the mobility of users with limited walking capacity.